1. Adverse drug reactions with nitrofurantoin

   News item 21 March 2020 Pages: 1 - 1

2. Australia's TGA offers tips on how to identify counterfeit medicines

   News item 21 March 2020 Pages: 2 - 2

3. New draft guidance evaluates safety of new antihyperglycaemics

   News item 21 March 2020 Pages: 3 - 3

4. Reports of adverse drug reactions in New Zealand during 2019

   News item 21 March 2020 Pages: 4 - 4

5. Strengthened warnings of neuropsychiatric events with montelukast

   News item 21 March 2020 Pages: 5 - 5

6. Three years of contraception required after acitretin use

   News item 21 March 2020 Pages: 6 - 6

7. Apixaban vs rivaroxaban in patients with atrial fibrillation

   Clinical study 21 March 2020 Pages: 7 - 7

8. Emtricitabine/tenofovir alafenamide not cost effective despite fewer AEs

   Clinical study 21 March 2020 Pages: 8 - 8

9. Levonorgestrel emergency contraceptive: most AEs not serious

   Clinical study 21 March 2020 Pages: 9 - 9

10. Medication overuse headache

    Clinical study 21 March 2020 Pages: 10 - 10

11. Photosensitivity with fluoroquinolones

    Clinical study 21 March 2020 Pages: 11 - 11

12. Safety, efficacy and total costs of multiple myeloma regimens

    Clinical study 21 March 2020 Pages: 12 - 12

13. Other adverse reaction research

    News item 21 March 2020 Pages: 13 - 13

14. Bacillus clausii

    Case report 21 March 2020 Pages: 14 - 14

15. Adalimumab

    Case report 21 March 2020 Pages: 15 - 15

16. Adalimumab

    Case report 21 March 2020 Pages: 16 - 16

17. Adalimumab/pentoxifylline/triamcinolone

    Case report 21 March 2020 Pages: 17 - 17

18. Afatinib/crizotinib/erlotinib

    Case report 21 March 2020 Pages: 18 - 18

19. Alemtuzumab

    Case report 21 March 2020 Pages: 19 - 19

20. Allopurinol

    Case report 21 March 2020 Pages: 20 - 20

21. Amantadine/memantine/olanzapine

    Case report 21 March 2020 Pages: 21 - 21

22. Amfetamine abuse

    Case report 21 March 2020 Pages: 22 - 22

23. Amikacin/avibactam/ceftazidime

    Case report 21 March 2020 Pages: 23 - 23

24. Anakinra/corticosteroids/immunosuppressants

    Case report 21 March 2020 Pages: 24 - 24

25. Antibacterials

    Case report 21 March 2020 Pages: 25 - 25

26. Antibacterials

    Case report 21 March 2020 Pages: 26 - 26

27. Antibacterials

    Case report 21 March 2020 Pages: 27 - 27

28. Anticoagulants/aspirin/warfarin

    Case report 21 March 2020 Pages: 28 - 28

29. Antineoplastics

    Case report 21 March 2020 Pages: 29 - 29

30. Antineoplastics

    Case report 21 March 2020 Pages: 30 - 30

31. Antineoplastics

    Case report 21 March 2020 Pages: 31 - 31

32. Antineoplastics

    Case report 21 March 2020 Pages: 32 - 32

33. Antineoplastics

    Case report 21 March 2020 Pages: 33 - 33

34. Antineoplastics

    Case report 21 March 2020 Pages: 34 - 34

35. Antineoplastics

    Case report 21 March 2020 Pages: 35 - 35

36. Antineoplastics

    Case report 21 March 2020 Pages: 36 - 36

37. Antineoplastics

    Case report 21 March 2020 Pages: 37 - 37

38. Antineoplastics

    Case report 21 March 2020 Pages: 38 - 38

39. Antineoplastics

    Case report 21 March 2020 Pages: 39 - 39

40. Antineoplastics

    Case report 21 March 2020 Pages: 40 - 40

41. Antineoplastics

    Case report 21 March 2020 Pages: 41 - 41

42. Antiretrovirals

    Case report 21 March 2020 Pages: 42 - 42

43. Antiretrovirals/bosentan interaction

    Case report 21 March 2020 Pages: 43 - 43

44. Antithymocyte-globulin/oseltamivir/sirolimus

    Case report 21 March 2020 Pages: 44 - 44

45. Antivirals

    Case report 21 March 2020 Pages: 45 - 45

46. Arginine

    Case report 21 March 2020 Pages: 46 - 46

47. Artesunate/ceftriaxone

    Case report 21 March 2020 Pages: 47 - 47

48. Atezolizumab

    Case report 21 March 2020 Pages: 48 - 48

49. Atorvastatin/clopidogrel/nifedipine interaction

    Case report 21 March 2020 Pages: 49 - 49

50. Atovaquone/proguanil

    Case report 21 March 2020 Pages: 50 - 50